At-home testing could transform the fight against the novel coronavirus.
Several testing experts, including, said the FDA's move is a step in the right direction and could encourage companies to pursue inexpensive, rapid, at-home tests.
The template also outlines how accurate the tests must be, with slightly lower standards than lab-based tests. Similar rapid tests used to diagnose strep throat miss as many as one in five people who are infected, so physicians normally send a throat culture to a lab to confirm the diagnosis, said Dr. Emily Volk, president-elect of the College of American Pathologists. Such confirmatory testing usually takes several days.
Another $50 million is available to scale up manufacturing and could be distributed to any contestant during the competition, said Jeff Huber, president and co-founder of OpenCovidScreen, whose company is launching the competition in collaboration with XPRIZE.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA authorizes first COVID-19 test for people without symptomsNew research finds similar levels of the virus in people who test positive with and without symptoms.
Weiterlesen »
Andy Cohen calls FDA rules on gay men donating plasma for COVID-19 ‘discriminatory’COVID-19 survivor Andy Cohen speaks out on being prohibited from donating plasma due to decades-old FDA guidelines limiting gay and bisexual men from donating blood.
Weiterlesen »
WSJ News Exclusive | FDA Nears Decision Authorizing Covid-19 Treatment With Convalescent PlasmaThe FDA is nearing a decision to authorize emergency use of antibody-rich blood plasma from recovered Covid-19 patients for treating people infected with the coronavirus
Weiterlesen »
FDA could authorize COVID-19 treatment with convalescent plasma as early as next week: WSJThe Food and Drug Administration (FDA) could authorize emergency use of antibody-rich blood plasma from recovered COVID-19 patients to treat people infected with the coronavirus as early as next week, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
Weiterlesen »
FDA opens door to rapid, at-home screening for COVID-19The FDA has opened the door to COVID-19 testing that could be fast, cheap, and done at home. Experts say these tests could transform daily life.
Weiterlesen »
FDA opens door to rapid, at-home testing for COVID-19The FDA on Wednesday opened the door to COVID-19 testing that could be fast, cheap, and handled entirely at home — if companies don't find the rules too burdensome.
Weiterlesen »